IL96134A0 - Substituted cycloalkano(b)-dihydroindole-and-indolesulphonamides,their preparation and pharmaceutical compositions containing them - Google Patents

Substituted cycloalkano(b)-dihydroindole-and-indolesulphonamides,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL96134A0
IL96134A0 IL96134A IL9613490A IL96134A0 IL 96134 A0 IL96134 A0 IL 96134A0 IL 96134 A IL96134 A IL 96134A IL 9613490 A IL9613490 A IL 9613490A IL 96134 A0 IL96134 A0 IL 96134A0
Authority
IL
Israel
Prior art keywords
dihydroindole
indolesulphonamides
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL96134A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL96134A0 publication Critical patent/IL96134A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL96134A 1989-10-30 1990-10-26 Substituted cycloalkano(b)-dihydroindole-and-indolesulphonamides,their preparation and pharmaceutical compositions containing them IL96134A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898924392A GB8924392D0 (en) 1989-10-30 1989-10-30 Substituted cycloalkano/b/dihydroindole-and-indolesulphonamides

Publications (1)

Publication Number Publication Date
IL96134A0 true IL96134A0 (en) 1991-07-18

Family

ID=10665396

Family Applications (1)

Application Number Title Priority Date Filing Date
IL96134A IL96134A0 (en) 1989-10-30 1990-10-26 Substituted cycloalkano(b)-dihydroindole-and-indolesulphonamides,their preparation and pharmaceutical compositions containing them

Country Status (21)

Country Link
US (3) US5039670A (fi)
EP (1) EP0425906B1 (fi)
JP (1) JPH03151360A (fi)
KR (1) KR910007876A (fi)
CN (1) CN1051354A (fi)
AT (1) ATE102185T1 (fi)
AU (1) AU628665B2 (fi)
CA (1) CA2028621A1 (fi)
DE (1) DE59004764D1 (fi)
DK (1) DK0425906T3 (fi)
ES (1) ES2062250T3 (fi)
FI (1) FI905294A0 (fi)
GB (1) GB8924392D0 (fi)
HU (1) HUT57190A (fi)
IE (1) IE903869A1 (fi)
IL (1) IL96134A0 (fi)
NO (1) NO904487L (fi)
NZ (1) NZ235860A (fi)
PH (1) PH27484A (fi)
PT (1) PT95728A (fi)
ZA (1) ZA908637B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0528762B1 (de) * 1991-08-15 1997-05-07 Novartis AG N-Acyl-N-Heterocyclyl- oder Naphthylalkyl-Aminosäuren als Angiotensin II Antagonisten
DE19506739A1 (de) * 1995-02-27 1996-08-29 Bayer Ag [3-Amino]-tetrahydrocarbazol-propansäureester
US5708187A (en) * 1996-06-27 1998-01-13 Eli Lilly And Company 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta 7,6-B!indoles: New 5-HT1F agonists
WO2003097598A1 (fr) * 2002-05-16 2003-11-27 Shionogi & Co., Ltd. Composé comprenant un antagonisme du récepteur de pdg2
WO2003097042A1 (fr) * 2002-05-16 2003-11-27 Shionogi & Co., Ltd. Antagoniste de recepteur de pdg2
JP2007501284A (ja) * 2003-06-10 2007-01-25 スミスクライン ビーチャム コーポレーション テトラヒドロカルバゾール誘導体およびそれらの薬学的使用
DK1902026T3 (da) * 2005-06-24 2010-04-26 Lilly Co Eli Tetrahydrocarbazol-derivater, der kan anvendes som androgen-receptor-modulatorer (SARM)
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators
UA98777C2 (en) * 2006-11-20 2012-06-25 Эли Лилли Энд Компани Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators
CN101434571B (zh) * 2007-11-13 2012-05-30 杭州容立医药科技有限公司 环烷并[1,2-b]吲哚磺酰胺、其异构体或其盐的合成方法
PT2297100E (pt) * 2008-05-16 2013-01-24 Lilly Co Eli Moduladores dos receptores de andrógenos tetra-hidrociclopenta[b]indoles
LT3119779T (lt) 2014-03-17 2018-09-10 Idorsia Pharmaceuticals Ltd Azaindolo acto rūgšties dariniai ir jų panaudojimas kaip prostaglandino d2 receptoriaus moduliatorių
MX2018003202A (es) 2015-09-15 2018-06-08 Idorsia Pharmaceuticals Ltd Formas cristalinas.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3514696A1 (de) * 1985-04-24 1986-11-06 Bayer Ag, 5090 Leverkusen N-indolylethyl-sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
IL81325A (en) * 1986-01-23 1990-11-29 Merck Frosst Canada Inc Tetrahydrocarbazole 1-alkanoic acids and pharmaceutical compositions containing them
US4808608A (en) * 1986-01-23 1989-02-28 Merck & Co., Inc. Tetrahydrocarbazole 1-alkanoic acids, pharmaceutical compositions and use
DE3631824A1 (de) * 1986-02-21 1988-03-31 Bayer Ag Cycloalkano(1.2-b)indol-sulfonamide
US4940719A (en) * 1986-03-27 1990-07-10 Merck Frosst Canada, Inc. Tetrahydrocarbazole esters, pharmaceutical compositions and use
DE3613623A1 (de) * 1986-04-23 1987-10-29 Bayer Ag N-dihydroindolylethyl-sulfonamide

Also Published As

Publication number Publication date
HUT57190A (en) 1991-11-28
NO904487L (no) 1991-05-02
PH27484A (en) 1993-07-23
IE903869A1 (en) 1991-05-08
EP0425906B1 (de) 1994-03-02
DK0425906T3 (da) 1994-04-11
EP0425906A2 (de) 1991-05-08
ATE102185T1 (de) 1994-03-15
PT95728A (pt) 1991-09-13
NO904487D0 (no) 1990-10-17
US5096897A (en) 1992-03-17
NZ235860A (en) 1992-09-25
ES2062250T3 (es) 1994-12-16
AU6384890A (en) 1991-06-20
KR910007876A (ko) 1991-05-30
CA2028621A1 (en) 1991-05-01
ZA908637B (en) 1991-08-28
DE59004764D1 (de) 1994-04-07
AU628665B2 (en) 1992-09-17
EP0425906A3 (en) 1992-01-22
JPH03151360A (ja) 1991-06-27
US5374647A (en) 1994-12-20
US5039670A (en) 1991-08-13
GB8924392D0 (en) 1989-12-20
FI905294A0 (fi) 1990-10-26
CN1051354A (zh) 1991-05-15
HU906925D0 (en) 1991-05-28

Similar Documents

Publication Publication Date Title
IL96134A0 (en) Substituted cycloalkano(b)-dihydroindole-and-indolesulphonamides,their preparation and pharmaceutical compositions containing them
MY109669A (en) N,o-sulphated heparosans, process for, preparing them and pharmaceutical compositions containing them
MX9604020A (es) Arilalquildiazinonas.
FR2645866B1 (fr) Nouvelles lipopolyamines, leur preparation et leur emploi
GEP20002210B (en) Acridine Derivatives
IL123293A (en) Piperidine derivatives, their preparation and pharmaceutical compositions containing them
CA2067184A1 (en) New linker for bioactive agents
HUT66370A (en) Polymers containing diester units and process for producing thereof
GB1525762A (en) Quaternary ammonium polymers
IL102758A (en) Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them
ES8604985A1 (es) Un procedimiento para producir un complejo de platino-diamino
IL105111A (en) SEMI-SYNTHETIC GLYCOSAMINOGLYCANS CONTAINING a-L- GALACTURONIC ACID SUBSTITUTED WITH NUCLEOPHILIC RADICALS IN POSITION 3 AND THEIR PREPARATION
IL114833A (en) Anthracyclinone derivatives for use as medicaments or for the manufacture of a medicament and pharmaceutical compositions comprising said derivatives for the treatment of amyloidosis, some such derivatives and processes for their preparation
CA2121997A1 (en) 3-deoxy oligosaccharides, processes for preparing them and pharmaceutical compositions containing them
MY114282A (en) Anthracycline derivatives
ES8407477A1 (es) Procedimiento de preparar nuevos derivados de sales inertes de hidroxido de aminopiridinio y sus sales correspondientes
IL97158A0 (en) Side-chain homologous vitamin d derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
TW369531B (en) New taxoids, their preparation and pharmaceutical compositions containing them
HUT58065A (en) Process for producing new 4'-epi-4'-aminoanthracyclines and pharmaceutical composiktions comprising same
IL98117A0 (en) 3'-deamino-4'-deoxy-4'-amino-8-fluoroanthracyclines,their preparation and pharmaceutical compositions containing them
MY108826A (en) (alpha)-aryl-(alpha) hydroxy-(beta)-imidazolindyl-propionamides
EP0204172A3 (en) Phenylpyrazine derivatives, processes for preparing them, pharmaceutical composition and use
HUP9802072A2 (hu) Benzo-tiopiráno-indazol-származékok és az ezeket tartalmazó gyógyszerkészítmények